OpenVSafe by OpenVAERS
Search V-safe

96Y-12266-79296

2 vaccinations 9 coded responses 15 check-ins 9 free-text entries 3 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
019 / MA
Registered
2021-04-19
Relationship
Self
Race
White
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-27
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-19
    Registered in v-safe
  3. 2021-04-19
    Dose 2 — Pfizer-BioNTech
  4. 2021-04-19
    Survey response — day 0, dose 2
    MedDRA: Lip swelling, Pruritus — Feeling: Good · Site: Pain · Chills, Fatigue or tiredness
    Free text: Swollen lip and itchy face and neck
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-21
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-04-22
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cough — Feeling: Good · Joint pains · Be unable to do your normal daily activities
    Free text: Dry coughing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cough — Feeling: Good · Site: Pain
    Free text: Dry coughing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Joint pains
    Adult check-in
  9. 2021-04-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Condition aggravated, Pre-existing disease — Feeling: Good · Muscle or body aches · Be unable to do your normal daily activities
    Free text: Intense menstrual pain after months controlled with hormone, anti-spasm and anti-inflammatory medication.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-26
    Survey response — day 7, dose 2
    MedDRA: Dysmenorrhoea, Inflammation — Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities
    Free text: Intense menstruation pain and inflammation even with medication.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-05-03
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  12. 2021-05-10
    Survey response — day 21, dose 2
    MedDRA: Dermatitis, Hypersensitivity — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Alergies, nasal and heightened dermatitis bouts.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  13. 2021-05-17
    Survey response — day 28, dose 2
    MedDRA: Hypersensitivity, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Severe allergy for over a week.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-05-17
    Report sent to call center — day 28, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  15. 2021-05-24
    Survey response — day 35, dose 2
    MedDRA: Eye disorder, Hypersensitivity, Office visit — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Ongoing allergy. Eyes got worse over the week, needing to get multiple meds and taking trips to the pharmacy. Very unusual in me. · Healthcare visit (other): Pharmacy.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-05-24
    Report sent to call center — day 35, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  17. 2021-06-02
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-07-20
    Health check-in — 3 months, dose 2
    Feeling: Fair
    Adult check-in
  19. 2021-10-18
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-04-07
  21. 2022-04-12
    Call successful
    Does not wish to fill out VAERS report
  22. 2022-04-25
    Survey response — 12 months, dose 2
    MedDRA: Anxiety, Depression — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Depression and anxiety.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-04-25
    Report sent to call center — 12 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  24. 2022-04-26
    Call successful
    Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill

Vaccinations

DoseDateManufacturerCo-administered
12021-03-27Pfizer-BioNTech
22021-04-19Pfizer-BioNTech

Call center

3 call center cases

3 successful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 7 — day 0, dose 2

2021-04-19

Systemic reaction (other): Swollen lip and itchy face and neck

Release 7 — days 1–6 daily, dose 2

2021-04-22

Systemic reaction (other): Dry coughing

2021-04-23

Systemic reaction (other): Dry coughing

2021-04-25

Systemic reaction (other): Intense menstrual pain after months controlled with hormone, anti-spasm and anti-inflammatory medication.

Release 8 — day 7, dose 2

2021-04-26

Systemic reaction (other): Intense menstruation pain and inflammation even with medication.

Release 8 — day 21, dose 2

2021-05-10

Symptoms: Alergies, nasal and heightened dermatitis bouts.

Release 8 — day 28, dose 2

2021-05-17

Symptoms: Severe allergy for over a week.

Release 8 — day 35, dose 2

2021-05-24

Symptoms: Ongoing allergy. Eyes got worse over the week, needing to get multiple meds and taking trips to the pharmacy. Very unusual in me.
Healthcare visit (other): Pharmacy.

Release 11 — 12 months, dose 2

2022-04-25

Symptoms: Depression and anxiety.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit ✓ ✓ ✓
SDAnxiety · · ✓
SDDepression · · ✓
SDDermatitis ✓ ✓ ✓
SDEye disorder ✓ ✓ ✓
SDHypersensitivity ✓ ✓ ✓
SDPre-existing disease · · ✓
SROCondition aggravated ✓ ✓ ✓
SROCough ✓ ✓ ✓
SRODysmenorrhoea ✓ ✓ ✓
SROInflammation ✓ ✓ ✓
SROLip swelling ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROPruritus ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release